Skip to main content
Heart Donate
Heart Donate
Search

Support WBUR

Controversy Continues Over Muscular Dystrophy Drug, Despite FDA Approval

04:46
Duchenne muscular dystrophy patients Jack Willis (center), Nolan Willis (right) and Max LeClaire, attended the opening of Sarepta Therapeutics new headquarters in Cambridge, Mass., in 2014. (Boston Globe via Getty Images)
Duchenne muscular dystrophy patients Jack Willis (center), Nolan Willis (right) and Max LeClaire, attended the opening of Sarepta Therapeutics new headquarters in Cambridge, Mass., in 2014. (Boston Globe via Getty Images)

Support WBUR

Support WBUR

Listen Live
Loading...